1. Home
  2. KW vs MNKD Comparison

KW vs MNKD Comparison

Compare KW & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KW
  • MNKD
  • Stock Information
  • Founded
  • KW 1977
  • MNKD 1991
  • Country
  • KW United States
  • MNKD United States
  • Employees
  • KW N/A
  • MNKD N/A
  • Industry
  • KW Real Estate
  • MNKD Biotechnology: Pharmaceutical Preparations
  • Sector
  • KW Finance
  • MNKD Health Care
  • Exchange
  • KW Nasdaq
  • MNKD Nasdaq
  • Market Cap
  • KW 1.4B
  • MNKD 1.4B
  • IPO Year
  • KW 1992
  • MNKD 2004
  • Fundamental
  • Price
  • KW $6.14
  • MNKD $4.63
  • Analyst Decision
  • KW Hold
  • MNKD Buy
  • Analyst Count
  • KW 1
  • MNKD 6
  • Target Price
  • KW $13.00
  • MNKD $8.92
  • AVG Volume (30 Days)
  • KW 906.4K
  • MNKD 1.6M
  • Earning Date
  • KW 05-07-2025
  • MNKD 05-08-2025
  • Dividend Yield
  • KW 7.80%
  • MNKD N/A
  • EPS Growth
  • KW N/A
  • MNKD 215.86
  • EPS
  • KW N/A
  • MNKD 0.10
  • Revenue
  • KW $503,500,000.00
  • MNKD $297,595,000.00
  • Revenue This Year
  • KW $30.34
  • MNKD $14.23
  • Revenue Next Year
  • KW $4.80
  • MNKD $14.56
  • P/E Ratio
  • KW N/A
  • MNKD $46.60
  • Revenue Growth
  • KW N/A
  • MNKD 32.50
  • 52 Week Low
  • KW $6.28
  • MNKD $4.17
  • 52 Week High
  • KW $11.88
  • MNKD $7.63
  • Technical
  • Relative Strength Index (RSI)
  • KW 32.27
  • MNKD 41.14
  • Support Level
  • KW $6.33
  • MNKD $4.87
  • Resistance Level
  • KW $6.86
  • MNKD $5.05
  • Average True Range (ATR)
  • KW 0.28
  • MNKD 0.18
  • MACD
  • KW 0.07
  • MNKD 0.02
  • Stochastic Oscillator
  • KW 6.49
  • MNKD 32.86

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: